We are live on ! Find out more
NYMX

Nymox Pharmaceutical Corp
NYMX

Delisted

NYMX was delisted on the 6th of July, 2023.

Back to rankings

34 hedge funds and large institutions have $495K invested in Nymox Pharmaceutical Corp in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% less funds holding

Funds holding: 39 → 34 (-5)

16% less capital invested

Capital invested by funds: $590K → $495K (-$95.5K)

22% less call options, than puts

Call options by funds: $7K | Put options by funds: $9K

38% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 8

45% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 11

Holders
34
Holders Change
-5
Holders Change %
-12.82%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
5
Reduced
8
Closed
11
Calls
$7K
Puts
$9K
Net Calls
-$2K
Net Calls Change
+$7K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$15.1K
2
Morgan Stanley
Morgan Stanley
New York
+$12K
3
Brown Advisory
Brown Advisory
Maryland
+$11.1K
4
GG
Gofen & Glossberg
Illinois
+$9.94K
5
CAN
Cetera Advisor Networks
California
+$6.81K

Top Sellers

Rank Fund Capital Flow
1
PAG
Private Advisor Group
New Jersey
-$37K
2
WB
Webster Bank
Connecticut
-$35K
3
WAM
Warberg Asset Management
Illinois
-$22K
4
CS
Credit Suisse
Switzerland
-$13K
5
BAS
Brown Advisory Securities
Maryland
-$12K
Name Holding Trade Value Shares
Change 		Change in
Stake
Group One Trading
26
Group One Trading
Illinois
$3K +$2.37K +5,950 New
BWA
27
BDO Wealth Advisors
Florida
$2K – – –
Bank of America
28
Bank of America
North Carolina
$1K -$788 -1,982 -61%
BNP Paribas Financial Markets
29
BNP Paribas Financial Markets
France
$499 -$158 -397 -25%
PAG
30
Private Advisor Group
New Jersey
– -$37K -85,100 Closed
WB
31
Webster Bank
Connecticut
– -$35K -80,000 Closed
WAM
32
Warberg Asset Management
Illinois
– -$22K -50,500 Closed
CS
33
Credit Suisse
Switzerland
– -$13K -30,000 Closed
BAS
34
Brown Advisory Securities
Maryland
– -$12K -28,000 Closed
Renaissance Technologies
35
Renaissance Technologies
New York
– -$9K -19,742 Closed
LNC
36
Lincoln National Corp
Pennsylvania
– -$4K -10,315 Closed
Simplex Trading
37
Simplex Trading
Illinois
– -$1.59K -3,990 -78%
SIAP
38
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
– -$1K -2,500 Closed
Citigroup
39
Citigroup
New York
– -$1K -1,474 Closed
UBS Group
40
UBS Group
Switzerland
– -$219 -550 -59%
Royal Bank of Canada
41
Royal Bank of Canada
Ontario, Canada
– +$260 +653 +391%
1
2

NYMX Hedge Fund Activity: Q3 2022 in Review

34 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Nymox Pharmaceutical Corp (NYMX) for Q3 2022, worth a combined $495K — down 16% from $590K a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of NYMX and 6 opened new positions — a net loss of 5 holders — while 8 trimmed existing stakes and 5 added.

The largest buyer was Millennium Management, opening a new position worth an estimated $15.1K. The largest seller was Private Advisor Group, exiting entirely with an estimated $37K sold.

  • 34 institutional investors held Nymox Pharmaceutical Corp (NYMX) as of Q3 2022, down from 39 in Q2 2022.
  • Funds reported $495K of Nymox Pharmaceutical Corp stock for Q3 2022, down 16% quarter-over-quarter.
  • 6 funds opened new Nymox Pharmaceutical Corp positions in Q3 2022 and 11 closed out, a net change of -5 holders.
  • The largest Nymox Pharmaceutical Corp buyer in Q3 2022 was Millennium Management, an estimated $15.1K added.
  • The largest Nymox Pharmaceutical Corp seller in Q3 2022 was Private Advisor Group, an estimated $37K sold.

Based on aggregated 13F filings for Q3 2022.